Hereditary spherocytosis classification

Jump to navigation Jump to search

Hereditary spherocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary spherocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hereditary spherocytosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary spherocytosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary spherocytosis classification

CDC on Hereditary spherocytosis classification

Hereditary spherocytosis classification in the news

Blogs on Hereditary spherocytosis classification

Directions to Hospitals Treating Hereditary spherocytosis

Risk calculators and risk factors for Hereditary spherocytosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Classification

  • HS classified on basis of underlying defect and pattern of inheritance. [1]
SPH1 ANK1 Ankyrin-1 AD Mild -moderate
AR Moderately severe -severe Often transfusion dependent
SPH2 SPTB Spectrin beta chain, erythrocytic AD Mild -moderate
AR Severe 1 fatal infantile case described
SPH3 SPTA1 Spectrin alpha chain, erythrocytic 1 AR Severe Transfusion dependent
SPH4 SLC4A1 Band 3 (anion transport protein) AD Mild -moderate Certain SLC4A1 pathogenic variants cause disease only when biallelic.
SPH5 EPB42 Protein 4.2 2 AR Mild -moderate 3 1 moderately severe case described
  • HS also classified on basis of severity as mentioned on the below table.[2]
Severity Hgb (g/dL) Reticulocytes (%) Splenectomy
Mild 11-15 3-8 Not necessary
Moderate 8-11.5 >8 Consider if activity level & quality of life are decreased
Moderately severe 6-8 ≥10 Indicated at age >5 yrs
Severe <6 ≥10 Indicated at age >3 yrs
Normal 1 11.7-15.7 (adult females) 13.3-17.7 (adult males) 0.5-1.5 2

References

  1. Duboucher C, Milhau S, Bouissou H (1987). "Isolated amyloidosis of the atrioventricular valves. A study of one case, curiously associated with diffuse storage of plant wax paraffin". Virchows Arch A Pathol Anat Histopathol. 410 (6): 541–5. PMID 3105174.
  2. Beauchamp-Nicoud A, Morle L, Lutz HU, Stammler P, Agulles O, Petermann-Khder R; et al. (2000). "Heavy transfusions and presence of an anti-protein 4.2 antibody in 4. 2(-) hereditary spherocytosis (949delG)". Haematologica. 85 (1): 19–24. PMID 10629586.

Template:WS Template:WH